All of these arguments are reduced to mere chatter, though, if comparative effectiveness research
doesn't result in physicians altering how they treat their individual patients.
He is a member of the National Institutes of Health's Comparative Effectiveness Research
Steering Committee and was a previous vice chair of the Medicare Evidence Development and Coverage Advisory Committee.
Committee on Comparative Effectiveness Research
By establishing legal incentives for evidence-based medicine, safe harbors founded on comparative effectiveness research
results also would reduce the need for defensive medicine and its unnecessary, costly treatments.
The IOM panel recommended that HHS set up an advisory body that would organize, monitor, and evaluate the implementation of a comparative effectiveness research
Among the recommendations ANA offered to the IOM Committee on Comparative Effectiveness Research
All these activities reflect an urgent and profound interest in comparative effectiveness research
While it may take some time to create an independent institute for comparative effectiveness, as outlined in President Obama's healthcare plan or 2008 legislation, comparative effectiveness research
can be enhanced through strategic federal agency funding, such as expanded discretionary funds for CMS's CED or increased funding for the Agency for Health Research and Quality (AHRQ), which already has begun to examine comparative effectiveness.
Max Baucus (D-MT) and Kent Conrad (D-ND) have introduced the Comparative Effectiveness Research
Act of 2008 for the development and use of comparative clinical-evidence studies in healthcare decision making.
3408, the Comparative Effectiveness Research
Act of 2008, the NLN took issue with the composition of the proposed Health Care Comparative Effectiveness Research
Institute mandated in the legislation.
NPC is actively engaged in conducting health care policy research on understanding the role and value of pharmaceuticals within the current and evolving payment and delivery models, the challenges of individual patient treatment effects and the utilization of real-world evidence and comparative effectiveness research
Comparative effectiveness research
of complementing work packages include gender-related analysis, systematic review of evidence, cost-effectiveness analysis, and health-related quality of life.
Specific topics include: research and development contract terms in the bio/pharmaceutical sector; effects of regulation on drug launch and pricing in interdependent markets; the effect of pharmaceutical innovation on the functional limitations of elderly Americans; comparative effectiveness research
, technological abandonment, and health care spending; the influence of initial signals of quality on the diffusion of new cancer drug treatments; technology diffusion and substitution of medical innovations; and health insurance and hospital technology adoption.
Comparative effectiveness research
is designed to inform health-care decisions by providing evidence on the effectiveness, benefits, and harms of different treatment options.
Much of the dialogue around personalized healthcare, comparative effectiveness research
and evidence-based medicine (EBM) has focused on the cost of the scientific and biotechnology breakthroughs we have witnessed in recent years, as well as the ethical, regulatory and reimbursement changes required in supporting this new model of care.